Advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB15627 | Dostarlimab | An anti-PD-1 monoclonal antibody used in the treatment of mismatch repair deficient endometrial cancers and solid tumours with no alternative treatment options. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB15627 | Dostarlimab | Programmed cell death protein 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|